This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

ERLEADA - TITAN Study

Last Updated: 02/19/2025

Summary

A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:

  • ERLEADA® (apalutamide) - TITAN Study
    • Minimum requirement to access interactive content: Adobe Acrobat Reader
  • An overview of the TITAN study design and results is available in video format: LINK.
  • The executive summary infographic of the iPDF content is provided below.